Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Childs

Showing results (61-70 of 86) with videos related to

Pageof 9
Sort By:
Cancer Immunology, Immunotherapy : CII|December 27, 2011
Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapyKatayoun Rezvani, Agnes S M Yong, Stephan Mielke, et al.
Bone Marrow Transplantation|September 9, 2024
Durable remission of refractory and advanced stage mycosis fungoides/sezary syndrome utilizing an "outpatient" alemtuzumab, fludarabine-based reduced intensity allogeneic hematopoietic cell transplantationPhuong Vo, Ramaprasad Srinivasan, Enkhtsetseg Purev, et al.
Blood|January 10, 2002
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndromeElizabeth M Kang, Moniek de Witte, Harry Malech, et al.
Blood|October 17, 2008
Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomibAgnes S M Yong, Keyvan Keyvanfar, Nancy Hensel, et al.
Pediatric Transplantation|March 8, 2013
Successful autologous cord blood transplantation in a child with acquired severe aplastic anemiaDavid Buchbinder, Loah Hsieh, Geetha Puthenveetil, et al.
Cytotherapy|May 17, 2014
The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approachesNatasha A Jain, Kit Lu, Sawa Ito, et al.
Blood|June 28, 2003
Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantationKatayoun Rezvani, Matthias Grube, Jason M Brenchley, et al.
American Journal of Physiology. Renal Physiology|February 29, 2008
Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injuryHideo Yasuda, Asada Leelahavanichkul, Shinichiro Tsunoda, et al.
Stress (Amsterdam, Netherlands)|March 8, 2016
Documenting stress in caregivers of transplantation patients: initial evidence of HPA dysregulationMargaret F Bevans, Alyson Ross, Leslie Wehrlen, et al.
British Journal of Haematology|March 1, 2011
A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteersSteven J Lemery, Matthew M Hsieh, Aleah Smith, et al.
Pageof 9

Showing results (61-70 of 86) with videos related to

Sort By:
Pageof 9
Cancer Immunology, Immunotherapy : CII|December 27, 2011
Lymphodepletion is permissive to the development of spontaneous T-cell responses to the self-antigen PR1 early after allogeneic stem cell transplantation and in patients with acute myeloid leukemia undergoing WT1 peptide vaccination following chemotherapyKatayoun Rezvani, Agnes S M Yong, Stephan Mielke, et al.
Bone Marrow Transplantation|September 9, 2024
Durable remission of refractory and advanced stage mycosis fungoides/sezary syndrome utilizing an "outpatient" alemtuzumab, fludarabine-based reduced intensity allogeneic hematopoietic cell transplantationPhuong Vo, Ramaprasad Srinivasan, Enkhtsetseg Purev, et al.
Blood|January 10, 2002
Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndromeElizabeth M Kang, Moniek de Witte, Harry Malech, et al.
Blood|October 17, 2008
Primitive quiescent CD34+ cells in chronic myeloid leukemia are targeted by in vitro expanded natural killer cells, which are functionally enhanced by bortezomibAgnes S M Yong, Keyvan Keyvanfar, Nancy Hensel, et al.
Pediatric Transplantation|March 8, 2013
Successful autologous cord blood transplantation in a child with acquired severe aplastic anemiaDavid Buchbinder, Loah Hsieh, Geetha Puthenveetil, et al.
Cytotherapy|May 17, 2014
The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approachesNatasha A Jain, Kit Lu, Sawa Ito, et al.
Blood|June 28, 2003
Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantationKatayoun Rezvani, Matthias Grube, Jason M Brenchley, et al.
American Journal of Physiology. Renal Physiology|February 29, 2008
Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injuryHideo Yasuda, Asada Leelahavanichkul, Shinichiro Tsunoda, et al.
Stress (Amsterdam, Netherlands)|March 8, 2016
Documenting stress in caregivers of transplantation patients: initial evidence of HPA dysregulationMargaret F Bevans, Alyson Ross, Leslie Wehrlen, et al.
British Journal of Haematology|March 1, 2011
A pilot study evaluating the safety and CD34+ cell mobilizing activity of escalating doses of plerixafor in healthy volunteersSteven J Lemery, Matthew M Hsieh, Aleah Smith, et al.
Pageof 9